Kempner Capital Management’s Enzo Biochem, Inc. ENZ Stock Holding History

Kempner Capital Management’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-25,475	Closed	-$17K	–	50
2025 Q2	$17K	Hold	25,475	–	–	0.01%	46
2025 Q1	$9K	Hold	25,475	–	–	0.01%	48
2024 Q4	$18K	Hold	25,475	–	–	0.01%	49
2024 Q3	$29K	Hold	25,475	–	–	0.01%	51
2024 Q2	$28K	Hold	25,475	–	–	0.01%	50
2024 Q1	$32K	Hold	25,475	–	–	0.02%	50
2023 Q4	$35K	Hold	25,475	–	–	0.02%	53
2023 Q3	$36K	Hold	25,475	–	–	0.02%	56
2023 Q2	$47K	Hold	25,475	–	–	0.03%	54
2023 Q1	$62K	Hold	25,475	–	–	0.04%	55
2022 Q4	$36.4K	Hold	25,475	–	–	0.02%	59
2022 Q3	$57K	Hold	25,475	–	–	0.04%	60
2022 Q2	$53K	Hold	25,475	–	–	0.03%	60
2022 Q1	$74K	Hold	25,475	–	–	0.04%	56
2021 Q4	$82K	Hold	25,475	–	–	0.05%	50
2021 Q3	$90K	Hold	25,475	–	–	0.05%	53
2021 Q2	$81K	Sell	25,475 -70,001	-73%	-$220K	0.05%	51
2021 Q1	$328K	Hold	95,476	–	–	0.19%	46
2020 Q4	$241K	Hold	95,476	–	–	0.16%	43
2020 Q3	$201K	Hold	95,476	–	–	0.16%	45
2020 Q2	$214K	Hold	95,476	–	–	0.17%	45
2020 Q1	$242K	Hold	95,476	–	–	0.21%	48
2019 Q4	$251K	Hold	95,476	–	–	0.16%	48
2019 Q3	$344K	Hold	95,476	–	–	0.23%	47
2019 Q2	$322K	Hold	95,476	–	–	0.21%	48
2019 Q1	$261K	Hold	95,476	–	–	0.17%	46
2018 Q4	$265K	Hold	95,476	–	–	0.18%	47
2018 Q3	$393K	Hold	95,476	–	–	0.25%	44
2018 Q2	$496K	Hold	95,476	–	–	0.33%	41
2018 Q1	$523K	Hold	95,476	–	–	0.36%	39
2017 Q4	$778K	Hold	95,476	–	–	0.49%	35
2017 Q3	$1M	Hold	95,476	–	–	0.66%	35
2017 Q2	$1.05M	Hold	95,476	–	–	0.69%	38
2017 Q1	$799K	Buy	95,476 +25,475	+36%	+$179K	0.53%	37
2016 Q4	$486K	Hold	70,001	–	–	0.35%	38
2016 Q3	$356K	Hold	70,001	–	–	0.25%	44
2016 Q2	$418K	Hold	70,001	–	–	0.27%	43
2016 Q1	$319K	Hold	70,001	–	–	0.19%	47
2015 Q4	$315K	Hold	70,001	–	–	0.18%	47
2015 Q3	$222K	Hold	70,001	–	–	0.13%	52
2015 Q2	$212K	Hold	70,001	–	–	0.11%	53
2015 Q1	$207K	Hold	70,001	–	–	0.13%	57
2014 Q4	$311K	Hold	70,001	–	–	0.14%	51
2014 Q3	$361K	Hold	70,001	–	–	0.15%	52
2014 Q2	$368K	Hold	70,001	–	–	0.15%	54
2014 Q1	$291K	Hold	70,001	–	–	0.12%	54
2013 Q4	$204K	Hold	70,001	–	–	0.09%	50
2013 Q3	$176K	Hold	70,001	–	–	0.07%	51
2013 Q2	$146K	Buy	+70,001	New	+$155K	0.06%	48

Kempner Capital Management's ENZ Position: Q3 2025 in Review

Kempner Capital Management sold out of Enzo Biochem, Inc. (ENZ) in Q3 2025, closing a stake of 25,475 shares — an estimated $17K sold.

Kempner Capital Management first reported a position in ENZ in Q2 2013 and held it in 49 quarters. The position peaked at $1.05M in Q2 2017. 0 funds tracked by Wall St. Rank hold ENZ as of Q3 2025.

Kempner Capital Management reported no remaining Enzo Biochem, Inc. position as of Q3 2025 after selling out during the quarter.
Kempner Capital Management sold 25,475 Enzo Biochem, Inc. shares in Q3 2025, an estimated $17K.
Kempner Capital Management first reported a position in Enzo Biochem, Inc. in Q2 2013 and held it in 49 quarters.
Kempner Capital Management's Enzo Biochem, Inc. position peaked at $1.05M in Q2 2017.
0 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q3 2025.

Based on Kempner Capital Management's 13F filing for Q3 2025, filed 16 Oct 2025.